Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12916-017-0884-7 http://scihub22266oqcxt.onion/10.1186/s12916-017-0884-7 C5454584!5454584!28571584     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       BMC+Med 2017 ; 15 (ä): ä Nephropedia Template TP {{tp|p=28571584|t=2017. Spotlight on landmark oncology trials: the latest evidence and novel trial designs |pdf=|usr=}}{{28571584}} gab.com Text Spotlight on landmark oncology trials: the latest evidence and novel trial designs JO: BMC Med http://www.kidney.de/pget.php?&tw=1&pmid=28571584 #FOAvip The era of precision oncology is marked with prominent successes in the therapy of advanced soft tissue sarcomas, breast cancer, ovarian cancer and haematological neoplasms, among others. Moreover, recent trials of immune checkpoint inhibitors in melanoma, non-small cell lung carcinoma, and head and neck cancers have significantly influenced the therapeutic landscape by providing promising evidence for immunotherapy efficacy in the adjuvant setting in high-risk locoregional disease. To speed up the introduction of targeted therapy for cancer patients, novel phase II trials are being designed, and may likely form the basis for the ?landmark trials? of the future. A special article collection in BMC Medicine, ?Spotlight on landmark oncology trials?, features articles from invited experts on recent clinical practice-changing trials. Twit Text FOAVip Spotlight on landmark oncology trials: the latest evidence and novel trial designs ????BMC Med http://www.kidney.de/pget.php?&tw=1&pmid=28571584 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28571584 #FOAvip English Wikipedia <ref>{{Cite pmid|28571584}}</ref> Spotlight on landmark oncology trials: the latest evidence and novel trial designs #MMPMID28571584 Earl H; Molica S; Rutkowski P BMC Med 2017[]; 15 (ä): ä PMID28571584show ga The era of precision oncology is marked with prominent successes in the therapy of advanced soft tissue sarcomas, breast cancer, ovarian cancer and haematological neoplasms, among others. Moreover, recent trials of immune checkpoint inhibitors in melanoma, non-small cell lung carcinoma, and head and neck cancers have significantly influenced the therapeutic landscape by providing promising evidence for immunotherapy efficacy in the adjuvant setting in high-risk locoregional disease. To speed up the introduction of targeted therapy for cancer patients, novel phase II trials are being designed, and may likely form the basis for the ?landmark trials? of the future. A special article collection in BMC Medicine, ?Spotlight on landmark oncology trials?, features articles from invited experts on recent clinical practice-changing trials. äSpotlight on landmark oncology trials: the latest evidence and novel t(epmc).pdf DeepDyve Pubget Overpricing